Page 1683 - Clinical Small Animal Internal Medicine
P. 1683
Index 1621
mucocutaneous pyoderma nonhemotropic Mycoplasma, congenital myesthenia gravis 805
VetBooks.ir mucosa‐associated lymphoid tissue mycotic meningoencephalitis 784 paraneoplastic syndromes
esophageal disorders
Ureaplasma, and L‐form
1464, 1464
558–560, 564
bacteria 931–935
(MALT) 1287
mucous membrane pemphigoid mycotoxin toxicity 441 1220–1221
(MMP) 542, 1428 mydriasis 824 seronegative myesthenia gravis
mucous membranes 121 myelodysplastic syndromes (MDS) 805–806
MUE see meningoencephalitis of 1229–1230 treatment 806
unknown etiology diagnosis 1230 myocardial disease
multicat environments see kennels and epidemiology 1229 arrhythmogenic right ventricular
multicat environments etiology/pathophysiology 1229 cardiomyopathy 263–265, 263,
multidrug‐resistant (MDR) history and clinical signs 1230 267, 269–272
staphylococci 1467–1468 signalment 1229 arterial thromboembolism 269
see also nocosomial and multidrug‐ treatment and prognosis 1230 canine 253–265
resistant infections myelography 797–798, 819 diagnosis 255–259, 255–257, 258,
multilobular osteochondrosarcoma myeloid neoplasia 1225–1229 264–265, 270–272, 271–272
(MLO) 1327, 1332 acute myeloid leukemia 1225–1227 dilated cardiomyopathy 253–262,
multiple endocrine neoplasia basophilic/eosinophilic leukemia and 255–257, 258, 260, 267, 269–271
(MEN) 1297 essential thrombocytopenia epidemiology 254, 263–264,
multiple myeloma (MM) 1228–1229 269–270
1241–1246, 1243 chronic myelogenous leukemia etiology/pathophysiology
multiple organ dysfunction syndrome 1227–1228 253–254, 263, 263, 267–270, 268
(MODS) 952 myeloproliferative neoplasms feline 267–274
MUO see meningoencephalitis of 1227–1229 history and clinical signs
unknown origin polycythemia vera 1228 254–255, 264, 270
mural masses 519 myelopathy 815–822 hypertrophic cardiomyopathy 265,
murmurs acute spinal cord dysfunction 267–273
canine myocardial disease 255 818–819 prognosis 262, 265, 273
cardiovascular disease 120, anomalies 820 restrictive cardiomyopathy 267,
123–124, 124–125 clinical signs 815–818, 816–817 269–270
feline myocardial disease degenerative myelopathy 820 signalment 254, 264, 270
270–271, 273 diagnostic approach 819–820 treatment 259–262, 260, 265,
pleural effusion 335 differential diagnosis 816, 272–273
respiratory pattern‐based approach 820–822 unclassified cardiomyopathy
to dyspnea 292 general proprioceptive ataxia 816 267, 270
valvular heart disease 247 history 815 myocardial hemangiosarcoma 1340,
muscle fasciculations 769 hyperesthesia 818 1344
muscle size/tone 732–735 inflammatory disease 821 myocarditis 414, 859
muscle weakness 82, 120–121 loss of nociception 818 myoclonus 769
muscular contractions 574 metabolic disease 820 myocytes 181
muscular dystrophy 570 neoplasia 820–821 myokymia 460, 769
MVD see microvascular dysplasia paresis/plegia 816–817, 821 myopathies 811–814
MVS see mitral valve stenosis pathophysiology 815 acute respiratory failure 382
mycobacteriosis 980–984 postural abnormalities 817–818 diagnosis 812–813
diagnosis 982, 982 spinal reflex abnormalities 818 epidemiology 811
epidemiology 980–981, 981 trauma 821 etiology/pathophysiology 811
etiology/pathophysiology 980 treatment 822 history and clinical signs
history and clinical signs 982, 982 vascular occlusive 811–812
public health implications disorders 821–822 prognosis 813
983–984 myeloproliferative neoplasms signalment 811, 812
signalment 981 (MPN) 1227–1229 treatment 813
treatment and prognosis myesthenia gravis (MG) 803–806 myosin heavy chain (MHC)
982–983, 983 acquired myesthenia isoform 181
Mycoplasma spp. 1035, 1037 gravis 804–805 myotonia 768
hemotropic Mycoplasma 927–930 clinical presentation 803–804 myrdiasis 753
